P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL

• Carsten Niemann,
• Mark-David Levin,
• Anders Österborg,
• Jeanette Lundin,
• Magdalena Kättström,
• Jeanette Vollerup,
• Caspar Da Cunha-Bang,
• Michael Foraux,
• Christian Brieghel,
• Fransien de Boer,
• Lisbeth Enggaard,
• Christian Bjorn Poulsen,
• Joanne Reekie,
• Rudi Agius

Affiliations

Carsten Niemann

1 Rigshospitalet, Department of Hematology, Copenhagen O, Denmark

Mark-David Levin

2 Albert Schweitzer

Anders Österborg

3 Karolinska

Jeanette Lundin

3 Karolinska

Magdalena Kättström

4 Örebro

Jeanette Vollerup

5 Rigshospitalet, CHIP

Caspar Da Cunha-Bang

1 Rigshospitalet, Department of Hematology, Copenhagen O, Denmark

Michael Foraux

2 Albert Schweitzer

Christian Brieghel

1 Rigshospitalet, Department of Hematology, Copenhagen O, Denmark

Fransien de Boer

6 Ikazia

Lisbeth Enggaard

1 Rigshospitalet, Department of Hematology, Copenhagen O, Denmark

Christian Bjorn Poulsen

7 Zealand University Hospital

Joanne Reekie

5 Rigshospitalet, CHIP

Rudi Agius

1 Rigshospitalet, Department of Hematology, Copenhagen O, Denmark